Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Happel David
Relationship:   President & CEO, Direc...
City:   Novato
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   644,289    

Indirect Shares

  0      
Direct Value   $2,905,363    

Indirect Value

  $0      
Total Shares   644,289      
Total Value   $2,905,363      


Horizon Pharma, Inc.
 $144,019 Sagimet Biosciences Inc.
 $2,761,344 Horizon Pharma, Inc.
 $144,019 Sagimet Biosciences Inc.
 $2,761,344
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    3   
    0    

     Stock price went up :

    2   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   2.0   
   0.0   
     Percentage Gain/Loss :
   28.7%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Horizon Pharma, Inc. HZNP EVP, Commercial Dev & ... 2017-10-25 5,089 2017-10-25 0    Premium*  
            Sagimet Biosciences Inc. SGMT President & CEO, Direc... 2024-03-26 639,200 2023-11-16 0    Premium*  
* Premium Members only  

Records found :    6         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SGMT Sagimet Biosciences Inc. President & CEO   •       •      –    2024-03-26 4 B $5.27 $63,731 D/D 12,100 639,200 2.81 %
SGMT Sagimet Biosciences Inc. President & CEO   •       •      –    2023-12-07 4 B $4.10 $6,560 D/D 1,600 627,100 2.81 %
SGMT Sagimet Biosciences Inc. President & CEO   •       •      –    2023-11-17 4 A $0.00 $0 D/D 624,910 625,500 0 -
SGMT Sagimet Biosciences Inc. President & CEO   •       •      –    2023-11-16 4 B $2.35 $1,387 D/D 590 590 2.73 %
HZNP Horizon Pharma, Inc. EVP, Commercial Dev & Strategy   •       –      –    2017-10-25 4 D $13.53 $56,150 D/D (4,150) 5,089 0 -
HZNP Horizon Pharma, Inc. EVP, Commercial Dev & Strategy   •       –      –    2017-10-25 4 OE $0.00 $0 D/D 7,953 9,239 0 -

  6  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed